APA (7th ed.) Citation

YS, T., C, C., H, L., Y, S., CW, T., K, Y., . . . DS, H. (2026). Robust cross-neutralizing antibody responses but variable cellular immunity following either Comirnaty and Spikevax JN.1-adapted mRNA vaccination in the elderly. Vaccine, 83, 128634. https://doi.org/10.1016/j.vaccine.2026.128634

Chicago Style (17th ed.) Citation

YS, Tang, et al. "Robust Cross-neutralizing Antibody Responses but Variable Cellular Immunity Following Either Comirnaty and Spikevax JN.1-adapted MRNA Vaccination in the Elderly." Vaccine 83 (2026): 128634. https://doi.org/10.1016/j.vaccine.2026.128634.

MLA (9th ed.) Citation

YS, Tang, et al. "Robust Cross-neutralizing Antibody Responses but Variable Cellular Immunity Following Either Comirnaty and Spikevax JN.1-adapted MRNA Vaccination in the Elderly." Vaccine, vol. 83, 2026, p. 128634, https://doi.org/10.1016/j.vaccine.2026.128634.